These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33622080)

  • 21. Culture of megakaryocytes and platelets from subcutaneous adipose tissue and a preadipocyte cell line.
    Matsubara Y; Murata M; Ikeda Y
    Methods Mol Biol; 2012; 788():249-58. PubMed ID: 22130712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of blood 'pharming': megakaryoctye transfusions as a source of platelets.
    Gollomp K; Lambert MP; Poncz M
    Curr Opin Hematol; 2017 Nov; 24(6):565-571. PubMed ID: 28985194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
    Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
    Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNAs can increase the efficiency of ex vivo platelet generation.
    Emmrich S; Henke K; Hegermann J; Ochs M; Reinhardt D; Klusmann JH
    Ann Hematol; 2012 Nov; 91(11):1673-84. PubMed ID: 22763947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A journey to produce platelets in vitro.
    Reems JA
    Transfusion; 2011 Nov; 51 Suppl 4():169S-176S. PubMed ID: 22074628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro platelet production].
    Dunois-Lardé C; Baruch D
    Transfus Clin Biol; 2011 Apr; 18(2):158-64. PubMed ID: 21411355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent lessons learned for ex-vivo platelet production.
    Tang A; Mendelson A
    Curr Opin Hematol; 2021 Nov; 28(6):424-430. PubMed ID: 34232141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of functional platelets by differentiated embryonic stem (ES) cells in vitro.
    Fujimoto TT; Kohata S; Suzuki H; Miyazaki H; Fujimura K
    Blood; 2003 Dec; 102(12):4044-51. PubMed ID: 12920021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro megakaryocyte production and platelet biogenesis: state of the art.
    Reems JA; Pineault N; Sun S
    Transfus Med Rev; 2010 Jan; 24(1):33-43. PubMed ID: 19962573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet production using adipose-derived mesenchymal stem cells: Mechanistic studies and clinical application.
    Ono-Uruga Y; Ikeda Y; Matsubara Y
    J Thromb Haemost; 2021 Feb; 19(2):342-350. PubMed ID: 33217130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production.
    Ito Y; Nakamura S; Sugimoto N; Shigemori T; Kato Y; Ohno M; Sakuma S; Ito K; Kumon H; Hirose H; Okamoto H; Nogawa M; Iwasaki M; Kihara S; Fujio K; Matsumoto T; Higashi N; Hashimoto K; Sawaguchi A; Harimoto KI; Nakagawa M; Yamamoto T; Handa M; Watanabe N; Nishi E; Arai F; Nishimura S; Eto K
    Cell; 2018 Jul; 174(3):636-648.e18. PubMed ID: 30017246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation, Cryopreservation, and Characterization of iPSC-Derived Megakaryocytes.
    Pogozhykh D; Blasczyk R; Figueiredo C
    Methods Mol Biol; 2021; 2180():539-554. PubMed ID: 32797433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manipulating megakaryocytes to manufacture platelets ex vivo.
    Karagiannis P; Eto K
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(Suppl 1):S47-53. PubMed ID: 26149050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
    Proulx C; Boyer L; Hurnanen DR; Lemieux R
    J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.
    De Bruyn C; Delforge A; Martiat P; Bron D
    Stem Cells Dev; 2005 Aug; 14(4):415-24. PubMed ID: 16137231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced Pluripotent Stem Cell-Derived Megakaryocytes and Platelets for Disease Modeling and Future Clinical Applications.
    Borst S; Sim X; Poncz M; French DL; Gadue P
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2007-2013. PubMed ID: 28982668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated Biophysical and Biochemical Signals Augment Megakaryopoiesis and Thrombopoiesis in a Three-Dimensional Rotary Culture System.
    Yang Y; Liu C; Lei X; Wang H; Su P; Ru Y; Ruan X; Duan E; Feng S; Han M; Xu Y; Shi L; Jiang E; Zhou J
    Stem Cells Transl Med; 2016 Feb; 5(2):175-85. PubMed ID: 26702125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Good Manufacturing Practice-Grade of Megakaryocytes Produced by a Novel Ex Vivo Culturing Platform.
    Guan X; Wang L; Wang H; Wang H; Dai W; Jiang Y
    Clin Transl Sci; 2020 Nov; 13(6):1115-1126. PubMed ID: 33030809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro generation of platelets: Where do we stand?
    Di Buduo CA; Kaplan DL; Balduini A
    Transfus Clin Biol; 2017 Sep; 24(3):273-276. PubMed ID: 28669522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-Dimensional Environment Sustains Hematopoietic Stem Cell Differentiation into Platelet-Producing Megakaryocytes.
    Pietrzyk-Nivau A; Poirault-Chassac S; Gandrille S; Derkaoui SM; Kauskot A; Letourneur D; Le Visage C; Baruch D
    PLoS One; 2015; 10(8):e0136652. PubMed ID: 26313154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.